TY - JOUR AU - Beksaç, M. Sinan AU - Aydın, Emine AU - Tuğral, Mert AU - Karaağaoğlu, Ergün PY - 2015/04/30 Y2 - 2024/03/29 TI - An Obstetrics Index for the Assessment of Risk Levels of “High Risk Pregnancy” Groups JF - Gynecology Obstetrics & Reproductive Medicine JA - Gynecol Obstet Reprod Med VL - 21 IS - 1 SE - Obstetrics; Maternal Fetal Medicine and Perinatology DO - UR - https://www.gorm.com.tr/index.php/GORM/article/view/37 SP - 10-13 AB - <p><strong>OBJECTIVE:</strong> To validate the usability of “Beksaç Obstetrics Index” (BOI/BOIp) in the evaluation of different high risk pregnancy groups.</p><p><strong>STUDY DESIGN:</strong> This study is consisted of 3 groups of patients; 1) Pregnancies without MTHFR polymorphisms (n=65), 2) Pregnancies with methylenetetrahydrofolate reductase (MTHFR; homozygous or compound heterozygous) polymorphisms (n=140), 3) Pregnancies with “autoimmune antibody positivity” without any other type of hereditary thrombophilia (Anti-dsDNA, anti-phospholipid Ig G/M, anti-cardiolipin Ig G/M, ASMA, APA, ENA, anti-mitochondrial antibodies) (n=76). In this study, BOI which is (number of child +π/10)/Gravida is used in order to demonstrate the risk levels/scale of different high risk pregnancy groups.</p><p><strong>RESULTS:</strong> The mean BOIp (±SD) values are 0,41±0,22; 0,29±0,21; and 0,40±0,23 for Control, MTHFR and Autoimmune groups respectively. We have demonstrated statistically significantly decreased BOIp level in MTHFR group compared to the other groups (p:0,002).</p><p><strong>CONCLUSION:</strong> We have demonstrated that BOI/BOIp can be used in the assessment of risk levels of different high risk pregnancy groups.</p> ER -